Huh Hoyoung's Form 4 filing
Akari Therapeutics Plc (AKTX) · filed Dec 18, 2025
- Accession no.
- 0001493152-25-028420
- Filed
- Dec 18, 2025, 9:57 PM ET
- Trade date
- Dec 16, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Huh HoyoungCIK 0001401267 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | American Depositary Shares representing Ordinary Shares | PPurchaseAcquired | +618,658 | –F4 | – | 618,658 | Direct | |
| Dec 16, 2025 | American Depositary Shares representing Ordinary Shares | PPurchaseAcquired | +618,658 | $0.4041F4 | +$249,999.7 | 618,658 | Direct | |
| Dec 16, 2025 | American Depositary Shares representing Ordinary Shares | PPurchaseAcquired | +3,093,293 | –F5 | – | 3,093,293 | Direct | |
| Dec 16, 2025 | American Depositary Shares representing Ordinary Shares | PPurchaseAcquired | +3,093,293 | $0.4041F5 | +$1,249,999.7 | 3,093,293 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
The combined purchase price per one PIPE PFW and accompanying PIPE Series G Warrant was $0.4041.
Referenced by the price of 2 transactions in Table II.
- F5
On December 16, 2025, the Reporting Person and the Issuer entered into a note cancellation and exchange agreement, pursuant to which, in exchange for the entire outstanding principal amount and all accrued interest on the Issuer's unsecured promissory note held by the Reporting Person, the Issuer issued to the Reporting Person (i) unregistered pre-funded warrants (the "Note Exchange Unregistered Pre-Funded Warrants") to purchase up to 3,093,293 ADSs, at a purchase price of $0.4041 per Note Exchange Unregistered Pre-Funded Warrant, and (ii) unregistered warrants to purchase up to 3,219,160 ADSs (the "Note Exchange Unregistered Warrants").
Referenced by the price of 2 transactions in Table II.
Remarks
See Exhibit 24 - Power of Attorney